Trials / Completed
CompletedNCT03886909
Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant
The Effects of a Prehabilitation Exercise Program in Adults Receiving a Hematopoietic Stem Cell Transplant
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Milton S. Hershey Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether patients are able to participate in a prehabilitation program (prior to the beginning of treatment) which includes: (1) a home-based exercise program or (2) just a prehabilitation education session.
Detailed description
Hematopoietic stem cell transplant may have the potential for severe side effects, including functional (reduced aerobic capacity, reduced muscle strength) and psychosocial (e.g. reduced quality of life, increased fatigue) detriments. Evidence shows that exercise is considered to be an effective treatment approach in hematopoietic stem cell transplant patients during and after treatment with regard to the above mentioned side-effects. Also, prehabilitative exercise in colon and lung cancer patients was shown as feasible and effective. However, no experience exists with regard to prehabilitation exercise in hematopoietic stem cell transplant patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Exercise | The exercise intervention is at least 2 weeks lasting (till the day transplant is taking place) 5-times weekly resistance training intervention combined with aerobic exercise (mostly walking). |
| BEHAVIORAL | Prehabilitation Education | Participant will receive a prehabilitation and stem cell education class which will be held at the Penn State Cancer Institute. |
Timeline
- Start date
- 2019-06-28
- Primary completion
- 2023-04-13
- Completion
- 2023-04-13
- First posted
- 2019-03-22
- Last updated
- 2023-07-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03886909. Inclusion in this directory is not an endorsement.